Lipid-induced microglia neuroinflammation

Lipid-induced microglia neuroinflammation is a pathological process characterized by the activation of microglial cells in response to elevated levels of lipids, particularly saturated fatty acids like palmitate and oxidized low-density lipoproteins (PubMed: 22503483). This phenomenon is a critical link between metabolic disorders (such as obesity and type 2 diabetes) and neurodegenerative conditions like Alzheimer's disease, where metainflammation in the brain leads to synaptic loss and cognitive decline (PubMed: 30639666). Mechanistically, lipids act as ligands for pattern recognition receptors, most notably Toll-like receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid cells 2 (TREM2), which trigger downstream signaling through the NF-κB pathway and the NLRP3 inflammasome (Nature: 10.1038/nature23874). Current therapeutic research focuses on modulating these lipid-sensing pathways using TLR4 antagonists, NLRP3 inhibitors, or GLP-1 receptor agonists to restore microglial homeostasis. While not a single protein, this process represents a major therapeutic axis for treating chronic neuroinflammatory diseases associated with metabolic dysfunction.

Other names

Lipid-mediated microglial activationFatty acid-induced neuroinflammationSaturated fatty acid-induced microglial polarizationMicroglial metainflammation

Inhibition of pattern recognition receptors (e.g., TLR4), blockade of the NLRP3 inflammasome, or modulation of metabolic pathways to reduce microglial pro-inflammatory polarization.